Gossamer Bio, Inc.
NASDAQ:GOSS
0.887 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 4.385 | 4.429 | 5.167 | 4.268 | 3.089 | 0.297 | 0 | 0 |
| Gross Profit
| -4.385 | -4.429 | -5.167 | -4.268 | -3.089 | -0.297 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 145.304 | 170.919 | 170.267 | 160.854 | 143.403 | 55.283 | 0.891 | 0 |
| General & Administrative Expenses
| 38.455 | 47.609 | 45.782 | 49.728 | 39.136 | 44.051 | 0.262 | 0.083 |
| Selling & Marketing Expenses
| -2.778 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 38.455 | 47.609 | 45.782 | 49.728 | 39.136 | 44.051 | 0.262 | 0.083 |
| Other Expenses
| 10 | 1.512 | 0.799 | -0.174 | 5.832 | 0.316 | 0 | 0 |
| Operating Expenses
| 183.759 | 218.528 | 216.049 | 210.582 | 182.539 | 99.334 | 1.153 | 0.083 |
| Operating Income
| -183.759 | -218.593 | -216.124 | -233.962 | -186.139 | -148.993 | -6.653 | -0.083 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.942 | -10.785 | -17.88 | -9.398 | 5.832 | -49.343 | -5.5 | 0 |
| Income Before Tax
| -179.817 | -229.378 | -234.004 | -243.36 | -180.307 | -146.969 | -6.771 | -0.083 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 10 | 10.85 | 15.072 | 8.224 | 0.511 | 2.036 | -5.382 | -0.083 |
| Net Income
| -179.817 | -240.228 | -249.076 | -251.584 | -180.818 | -146.969 | -6.771 | -0.083 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.18 | -2.84 | -3.33 | -3.67 | -3.3 | -2.43 | -0.27 | -0.003 |
| EPS Diluted
| -1.18 | -2.84 | -3.33 | -3.67 | -3.3 | -2.43 | -0.27 | -0.003 |
| EBITDA
| -172.152 | -215.433 | -214.489 | -207.314 | -178.939 | -97.001 | -1.153 | -0.083 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |